Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining 1.09% today. In the last week its performance is 0.66%, and 22.30% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 124.37, so today’s gain of 1.09% is a significant step towards its target price. The GAP today is therefore 0.34%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 25582.83, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 87.20%.

At the current price of 120.56, it has a dividend yield of *TBA, and its target price is 124.37. This is with a profit margin of 19.30%, and total debt/equity of 0.24. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 49.88, as well as a forward P/E of 35.49.

With a current EPS of 2.42, and a forecasted EPS growth for next year at 18.16%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 17.50%.

Performance for the year is 61.83%. Since its IPO date on 3/27/2000, the total performance to date is 52.65%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 971300, while its average volume is 1239.28. Whilst the total gain today was 1.09%, it did have a day high of -0.96%.

Volatility for this week has been at 1.76%, and 1.66% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 74.17%, while the 52-week-high has reached -0.96%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.30%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.40%. With a sales growth of 23.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.24, and has a current ratio of 4.2 and 3.4 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.85, and the P/S is 9.33, along with a P/B of 10.35. Meanwhile it has a p/cash of 24.13.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment